Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Goodwill (2019 - 2025)

Vivos Therapeutics' Goodwill history spans 7 years, with the latest figure at $8.6 million for Q4 2025.

  • Quarterly results put Goodwill at $8.6 million for Q4 2025, up 207.14% from a year ago — trailing twelve months through Dec 2025 was $8.6 million (up 207.14% YoY), and the annual figure for FY2025 was $8.6 million, up 207.14%.
  • Goodwill for Q4 2025 was $8.6 million at Vivos Therapeutics, up from $8.5 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $8.6 million in Q4 2025 to a low of $2.7 million in Q1 2021.
  • The 5-year median for Goodwill is $2.8 million (2021), against an average of $3.7 million.
  • The sharpest move saw Goodwill dropped 1.51% in 2022, then soared 207.14% in 2025.
  • Year by year, Goodwill stood at $2.8 million in 2021, then fell by 1.51% to $2.8 million in 2022, then changed by 0.0% to $2.8 million in 2023, then changed by 0.0% to $2.8 million in 2024, then soared by 207.14% to $8.6 million in 2025.
  • According to Business Quant data, Goodwill over the past three periods came in at $8.6 million, $8.5 million, and $8.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.